Fresenius SE & Co KGaA specializes in the design, manufacture, and marketing of drugs, equipment, and medical devices for clinical and home hospitalization. Its sales are primarily divided between hospital administration and engineering (64.3%) and perfusion and clinical nutrition (35.7%). Geographically, the company generates 72.4% of its sales in Europe, followed by North America (12.3%), Asia-Pacific (7.3%), Latin America (6.4%), and Africa (1.6%).